Skip to main content
Premium Trial:

Request an Annual Quote

Screenings Delayed

Researchers are investigating the effect of delayed cancer screenings due to the COVID-19 pandemic, the Associated Press reports.

Cancer screenings like colonoscopies, mammograms, lung scans, Pap tests, and more were put off as healthcare workers grappled with the onslaught of the pandemic. Now, as people reschedule their screenings, the AP writes that researchers are examining whether the delay has led to missed or more advanced diagnoses.

It reports that one group from the University of Cincinnati found that once lung cancer screenings started up again that 29 percent of people screened has suspicious findings, as compared to 8 percent in other years. Other researchers in the Netherlands, though, found no difference in breast cancer stages uncovered through mammograms, it says, while researchers in Boston found that just after screening resumed, the number of cancers uncovered was higher than usual, but then fell to typical levels a few months later.

The AP adds that at-home testing has also been adopted due to the pandemic.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.